Drug profile · INN
imipramine pamoate
IMIPRAMINE PAMOATE
imipramine pamoate (IMIPRAMINE PAMOATE) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — imipramine pamoate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
imipramine pamoate (IMIPRAMINE PAMOATE) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is imipramine pamoate?
imipramine pamoate (IMIPRAMINE PAMOATE) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for imipramine pamoate?
IMIPRAMINE PAMOATE is a marketed brand name for imipramine pamoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imipramine pamoate?
imipramine pamoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.